2nd SCI / RSC Symposium on Antimicrobial Drug Discovery

Introduction

Monday 12 - Tuesday 13 November 2018, SCI, London, UK
Monday 12 November

12:00 Registration, exhibition and lunch
13:00 Opening remarks
13:10 Antibiotics: challenges and opportunities - Dr Stephen Baker, GlaxoSmithKline
13:55 Rational and irrational discovery of novel interventions to treat drug-resistant infections - Prof Matt Cooper, University of Queensland and Inflazome
14:40 Flash poster presentations
15:00 Refreshment break and exhibition
15.30 Towards photopharmacological antimicrobial chemotherapy - Dr Matthew Fuchter, Imperial College London
16:00 SPARKing new antibiotic discovery - Wes King, The Pew Charitable Trusts
16.30 Research and development of new antimicrobial drugs and combinations: a not-for-profit approach - Prof Laura Piddock, Global Antibiotic Research & Development Partnership
17:15 Networking and refreshments

Tuesday 13 November

09:00 Rules for bacterial penetration - what we know and what we don't - Dr Paul Finn, Oxford Drug Design
09:30 Reversing efflux-mediated resistance to reinvent broad-spectrum antibiotics -Dr K Miraz Rahman, King’s College London
10:00 Predictive guidelines for compound accumulation lead to new broad-spectrum antibiotics - Prof Paul Hergenrother, University of Illinois
10:45 Refreshment break and exhibition
11:15 Non-hydroxamate LpxC inhibitors - Dr Alastair Parkes, Evotec
11:45 Novel immunotherapeutics to target Gram-negative bacterial infections - Dr Emma Leire, Centauri Therapeutics
12:15 Analysis of poatassium (K+) efflux systems (Kef) as an antibiotic target n pathogenic bacteria - Catherine Haslam, University of Oxford
12:30 Turning strength in to weakness: exploiting resistance as a novel therapeutic target - Lindsay Evans, Imperial College, London
12.45 MAPS: Multiparameter Assay for Profiling Susceptibiity - Dr Lisa Miller, University of York
13:00 Lunch and exhibition
14:00 Short antimicrobial peptides - their potential against multidrug-resistant bacteria - Dr Kai Hilpert, St George’s, University of London
14:30 From HTS to preclinical candidate: a novel small-molecule antibiotic for the treatment of drug-resistant Neisseria gonorrhoeae - Dr Paul Meo, Summit Therapeutics
15:00 Refreshment break and exhibition
15:30 Metallo β-lactamase inhibitors: an approach to combat the threat of emerging carbapenem resistance due to metallo β-lactamase enzymes in Gram-negative bacteria - Dr David Davies, AntaBio
16:00 Challenges in antibacterial drug discovery - Prof Ian Gilbert, University of Dundee
16:45 Closing remarks

Call for Poster Abstracts
Anyone wishing to present a poster should submit a one-page abstract to conferences@soci.org by Fri 14 September 2018 with "AMR-poster abstract" in the subject line. Selected poster presenters will be given the opportunity to give a flash presentation.
Bursaries
A limited number of bursaries are available to SCI/RSC student members to cover their registratation fees and contribute to their travel and accomodation costs. To apply for a bursary, please send an email to conferences@soci.org by Fri 14 September 2018 with "AMR II - burrsary application" in the subject line.
Exhibition and Sponsorship
An exhiition will take place alongside the conference. Companies and related organisations who may wish to exhibit, please email conferences@soci.org for further information and prices. Spaces are limited and will be allocated on a first-come first-served basis

#AntibioticGap